Skip to main content
Clinical Trials/ISRCTN96374224
ISRCTN96374224
Completed
N/A

Cancer: Life Affirming Survivorship support in Primary care (CLASP) Programme

niversity of Southampton0 sites2,728 target enrollmentAugust 9, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Malignant neoplasms of independent (primary) multiple sites
Sponsor
niversity of Southampton
Enrollment
2728
Status
Completed
Last Updated
last year

Overview

Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30826763 protocol (added 30/03/2020)

Registry
who.int
Start Date
August 9, 2017
End Date
March 31, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Southampton

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 15/03/2018:
  • 1\. Aged 18 years or over
  • 2\. Identifiable from GP case records
  • 3\. Have had breast, prostate or colorectal cancer.
  • 4\. Have finished primary cancer treatment (e.g. chemotherapy/radiotherapy courses) within last 10 years and primary treatment completed at least 1 month ago. This does not include active surveillance for prostate cancer patients or hormone therapy for any participants.
  • 5\. Have internet access
  • 6\. Have impaired quality of life (measured by EORTC)
  • Previous inclusion criteria
  • 1\. Be aged 18 yrs
  • 2\. Be identifiable from GP case records

Exclusion Criteria

  • Current exclusion criteria as of 15/03/2018:
  • 1\. Currently have cancer
  • 2\. Have had more than one other type of cancer (other than breast, prostate or colon) in the last 5 year
  • 3\. Have metastatic cancer
  • 4\. Receiving any cancer treatment other than hormone therapy currently or during the last month
  • 5\. Expecting to start any cancer treatment during the study period
  • 6\. Have severe mental health problems and/or major uncontrolled depression/schizophrenia or dementia
  • 7\. Had sarcoma/lymphoma of breast
  • 8\. Another participant of the study living in the same household
  • 9\. Currently have untreated cancer unless on active surveillance for prostate cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials